Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2010
12/08/2010CN101906093A Benzo five-membered unsaturated heterocycle compound and preparation method thereof
12/08/2010CN101906072A 3-phenylquinoline compounds as well as preparation method and application thereof
12/08/2010CN101906071A Dioxane-2-alkyl carbamates derivatives
12/08/2010CN101905033A Medicament microcapsule composite calcium deficiency calcium phosphate bone cement and use, preparation method and application thereof
12/08/2010CN101905011A Chinese medicinal composition for treating cervical spondylosis
12/08/2010CN101905007A Plaster for curing rheumatoid pains in neck, shoulders, waist and legs
12/08/2010CN101905006A External medicament for treating traumatic injury
12/08/2010CN101904992A Chinese medicinal preparation for treating traumatic injury
12/08/2010CN101904969A Traditional Chinese medicine composition for treating proliferative diseases and preparation method thereof
12/08/2010CN101904964A Cartialgenous bone strengthening capsule
12/08/2010CN101904958A Oral medicinal composition for treating fracture
12/08/2010CN101904953A Medicinal composition for diminishing inflammation and relieving pain and preparation method and use thereof
12/08/2010CN101904922A Plaster for treating pain caused by femoral head necrosis
12/08/2010CN101904910A Pharmaceutical composition for anti-inflammation and analgesia or anti-inflammation and immunization, and preparation method and use thereof
12/08/2010CN101904900A Medicament for treating rheumatic arthritis
12/08/2010CN101904887A Application of Saussurea involucrata culture in food and anti-inflammatory analgesic medicine
12/08/2010CN101904866A Medicinal composition for treating osteoporosis and preparation method thereof
12/08/2010CN101904855A Anti-anaphylaxis and sterilization combined injection
12/08/2010CN101904848A Use of HIF alpha stabilizers for enhancing erythropoiesis
12/08/2010CN101904844A Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative
12/08/2010CN101904843A Compound for preparing bone destruction inhibitor
12/08/2010CN101537003B Application of 7,3'-dimethoxy hesperetin in preparation of anti-inflammatory immune medicaments
12/08/2010CN101530540B Drug for curing rheumatoid arthritis
12/08/2010CN101518654B Method for synthesizing novel preparation capable of carrying glucocorticoid to be used as inflammation targeted drug
12/08/2010CN101485801B Plaster for treating osteoproliferation and preparation method thereof
12/08/2010CN101461895B Medicament composition for treating female climacteric syndrome and delaying age
12/08/2010CN101406540B Plaster for treating rheumatism
12/08/2010CN101390967B Medicine composition for treating osteoporosis
12/08/2010CN101380416B Medicine composition for treating osteoporosis and hyperosteogeny
12/08/2010CN101361924B Chinese prepared medicine for treating rachitis
12/08/2010CN101361874B Sinew and bone setting-up pellet and preparation method thereof
12/08/2010CN101357162B Traditional Chinese medicine capable of inducing menstruation and removing bloodstasis
12/08/2010CN101336949B Method for extracting polysaccharide and flavone from Gynura divaricata
12/08/2010CN101322754B Medicine for curing bone fracture
12/08/2010CN101301459B Medicated pillow
12/08/2010CN101297937B Chinese patent medicine formulation for treating cervical vertebra disease and preparation thereof
12/08/2010CN101292977B Pharmaceutical combination with stable strontium ranelate and its preparations
12/08/2010CN101284108B Traditional Chinese medicine combination for curing lumbar disease
12/08/2010CN101273057B Bone morphogenesis protein 2 active peptide and production method and application
12/08/2010CN101264198B Jinguhuo spraying agent and preparation thereof
12/08/2010CN101254239B Medicament for curing traumatic injury and method of preparing the same
12/08/2010CN101254155B Skin preparations for external use
12/08/2010CN101239133B Externally-applied plaster for treating protrusion of lumbar intervertebral disc
12/08/2010CN101167911B Plaster for treating hyperosteogeny and invertebral disc protrusion
12/08/2010CN101164568B External-applied traditional Chinese medicine for treating hyperosteogeny
12/08/2010CN101087615B N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same
12/08/2010CN101080402B Hydantoin derivatives useful as metalloproteinase inhibitors
12/08/2010CN101072752B Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same
12/08/2010CN101035791B Pyrrolo[1,2-D][1,2-4]triazine as inhibitors of c-JUN N terminal kinases (JNK) and P-38 kinases
12/08/2010CN101032336B Pearl flavone nutrient health care food and preparation process thereof
12/08/2010CN100998681B Traditional Chinese medicine composition for treating prolapse of lumbar intervertebral disc shift
12/07/2010US7847079 Albumin fusion proteins
12/07/2010US7846966 treating an estrogen-receptor related condition such as benign prostate hypertrophy or a menopausal complaints, comprising administering 4-benzyl-2-phenylchroman's such as 4-benzyl-3-methyl-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-6-ol, having surprisingly high estrogen receptor affinity
12/07/2010US7846927 N,N′-diphenylurea derivatives suitable as kinase inhibitors
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/07/2010US7846487 A neutraceutical comprising a dehydrated product of Type II collagen that retains its original natural structure and biological activity, sodium or potassium chloride and water; nonhydrolyzing; storage stability; antiarthritic agents;tablets; capsules; cream; lotion; biodrug; food supplements
12/07/2010US7846474 Administering a bisphosphonate until the bone mineral density is within a normal range, interrupting administration to enable the development of the sectional momentum of inertia, and resuming administration when the bone mineral density falls by 5-10% of the normal range
12/07/2010CA2488334C 24-sulfoximine vitamin d3 compounds
12/07/2010CA2456029C Stable emulsion composition
12/07/2010CA2436409C Kappa opioid receptor ligands
12/07/2010CA2256543C Methods and compositions useful for inhibition of angiogenesis
12/02/2010WO2010138095A1 Medicinal agent
12/02/2010WO2010137716A1 Orally disintegrating tablet which contains precipitated calcium carbonate as active ingredient
12/02/2010WO2010137484A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
12/02/2010WO2010137351A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010WO2010137350A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137349A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010136037A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/02/2010WO2010135915A1 Use of midkine and medical device containing midkine
12/02/2010WO2010117346A3 Stable pharmaceutical compositions with high bioavailability
12/02/2010US20100305308 Lactoferrin
12/02/2010US20100305204 Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists
12/02/2010US20100305200 Compounds that modulate intracellular calcium
12/02/2010US20100305194 Modified and stabilized gdf propeptides and uses thereof
12/02/2010US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna
12/02/2010US20100305187 Methods and compounds for treating diseases caused by reactive oxygen species
12/02/2010US20100305171 gout flares; ritonavir; side effect reduction of colchicine
12/02/2010US20100305166 Novel compounds
12/02/2010US20100305164 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
12/02/2010US20100305163 Pharmaceutical formulations comprising nsaid and proton pump inhibitor drugs
12/02/2010US20100305147 Chemically modified small molecules
12/02/2010US20100305123 Class of histone deacetylase inhibitors
12/02/2010US20100305121 Novel antagonists of the human fatty acid synthase thioesterase
12/02/2010US20100305114 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/02/2010US20100305106 Inhibitors of fatty acid uptake and methods of use
12/02/2010US20100305104 Oxadiazole Diaryl Compounds
12/02/2010US20100305098 Methods of use
12/02/2010US20100305094 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
12/02/2010US20100305092 Triazole oxadiazoles derivatives
12/02/2010US20100305089 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives
12/02/2010US20100305086 Pharmaceutical Compositions for the Treatment of Pain
12/02/2010US20100305070 Treatment or prophylaxis of proliferative conditions
12/02/2010US20100305039 Production of collagen in the milk of transgenic mammals
12/02/2010US20100305035 Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100305033 Hydroxyalkyl starch derivatives and process for their preparation
12/02/2010US20100305031 Peptide having an extending action for half-life of object peptide in plasma
12/02/2010US20100305024 Methods of inhibiting calcineurin with apoe analogs
12/02/2010US20100303899 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/02/2010US20100303898 Collagen dispersion and method of producing same